SGB treatments have been reported as beneficial in treating symptoms of PASC in small retrospective or case-series studies [31,32]. Prior initial studies comprised case reports that demonstrated significant efficacy of SGB for PASC with complete resolution of symptoms following two SGB treatments [10, 33-35]. Here, GPC3 is linked to long COVID-19.